Description: This report explores AI bias in insurance and health data, highlighting the ethical role of actuaries and offering cross-disciplinary guidance for fairer decision-making systems.

Description: Research Objective The Society of Actuaries Research Institute General Insurance Research Committee is seeking researchers to identify and analyze the various by-component inflationary forces on pet insurance affordability in the United States and Canada. In addition, we seek ideation of potential solutions that are likely to improve the affordability of pet insurance.

Description: The Society's Group Disability Insurance Experience Committee has completed their study of termination experience for the period 2009-2017. Included is a preliminary report, consolidated database (CDB), pivot tables and appendices.

Description: This project models and forecasts premature cardiovascular mortality, with a focus on two main risk factors - obesity status and education attainment level. It investigates the role of obesity and education in determining age-sex-specific premature cardiovascular mortality.

Description: LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA), and TAI have collaborated on an ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public. The Individual Life COVID-19 Project Work Group (Work Group) was formed as a collaboration of LIMRA, RGA, the SOA, and TAI to design, implement, and create the study and to produce and distribute a variety of analyses. This report is the fifth public release from this collaboration and contains the results of a cause of death analysis focused on how the rates of death for various causes were impacted throughout the pandemic period through the first quarter of 2021.

Description: The cost of prescription drugs is top of mind for consumers, payers and policymakers. Despite legislative efforts, such as the Inflation Reduction Act, the problem remains. More than 30% of all Americans say they have not taken prescription drugs as prescribed in the last 12 months because of the expense. The purpose of this paper is to discuss an alternative to policy solutions: reimagining pharmacy financing in the commercial space using a value-based reimbursement methodology that increases transparency, encourages competition, aligns stakeholder incentives and mitigates total cost of care (TCOC) increases. This paper will demonstrate that it is possible to implement such a methodology under the current infrastructure, but one can identify limitations.

Description: An in-depth analysis of the insurance landscape in China and seven key Asia Pacific Markets, focusing on the rapid development of critical illness products and the impact of technology on insurance purchasing behaviors.

Description: The Health Care Cost Trends Strategic Research Committee is looking for a research proposal that will examine the increased uptake of diabetes drugs on overall medical trends as well as the costs of individuals who are prescribed these drugs.

Description: This report presents the impact of Covid-19 on socioeconomic differentials in mortality in the United States. The study aims to understand how the pandemic affected various socioeconomic groups in the U.S. population.

Description: This report presents Phase 2 of the 2024 IDEC Study, analyzing individual disability income (IDI) claim recovery and mortality rates from 2006-2014. It expands Phase 1's scope—previously limited to 90-day elimination and To Age 65-70 benefit periods—to include additional elimination and benefit periods, examining variations by diagnosis, occupation class, claim year, and gender.